As India’s No. 1* pharmaceutical company in the cardio-metabolic therapy, Sun Pharma plays a significant role in addressing the growing burden of cardiovascular diseases,with strong leadership across lipid-lowering therapies and a substantial presence in anti-hypertensive and oral anti-diabetes treatments.